Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BCTG

BCTG Acquisition (BCTG) Stock Price, News & Analysis

About BCTG Acquisition Stock (NASDAQ:BCTG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$9.88
$11.47
52-Week Range
N/A
Volume
2,024 shs
Average Volume
36,697 shs
Market Capitalization
$218.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BCTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BCTG Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCTG Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
What Is an Acquisition Cost in Business Accounting?
ENER Accretion Acquisition Corp.
Intact Financial: Still Digesting The RSA Acquisition
See More Headlines

BCTG Stock Analysis - Frequently Asked Questions

BCTG Acquisition (BCTG) raised $145 million in an initial public offering (IPO) on Thursday, September 3rd 2020. The company issued 14,500,000 shares at $10.00 per share. SVB Leerink served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that BCTG Acquisition investors own include Churchill Capital Corp IV (CCIV), Great Elm Capital Group (GECC), Gores Holdings IV (GHIV), Mastech Digital (MHH), Mirati Therapeutics (MRTX), Novus Capital (NOVS) and CC Neuberger Principal Holdings II (PRPB).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:BCTG
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.23 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$218.05 million
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:BCTG) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners